RITM Australia attended the recent Wellness Expo in Darling Harbour, Sydney. The expo was focused on holistic approaches to staying healthy and keeping fit at home and at work.
During the event RITM’s team demonstrated the SCENAR technology – non-invasive, quick and effective pain relief electrotherapy.
We have been approached by over 30 visitors, looking for holistic and natural modality for mental and physical health.
Our team has provided demo treatments to over 15 people with various pain conditions and, all of them has experienced pain relief regardless of the pain level. The quickest treatment took one and a half minute with pain reduction of 4 (VAS from 7 to 3).
Our booth was so busy that we didn’t have time to make may photos.
We are really pleased with the show as this gave us the opportunity to show and provide more information about the brilliant SCENAR technology.
It was lovely to catch up with SCENAR Practitioners last week in Byron Bay during the Professional SCENAR Practical workshop.
We all had the chance to refresh our knowledge about some fundamental SCENAR Protocols such as 3+6 and their importance in the treatment outcome. Vera presented also a quick and very effective protocol for back pain from the 2017 SCENAR Conference followed by practicing it to each other. Instant pain relief and improved range of motion was the result of the treatments that we gave to each other.
Along with a sport Injuries protocol and questions and answers session, the attendees gained a new enthusiasm to practice their new knowledge with their clients.
Our next in our series of workshops – Sydney 6th of August, Harbourvew Hotel North Sydney.
Self-Controlled Energo-Neuro-Adaptive Regulator (SCENAR) device was introduced in 2006 as an alternative electrotherapy for pain in Korea. The aim of this study is to investigate the efficacy of SCENAR standing for SCENAR in patients with subacute neck pain following a rear-end collision.
A randomized and controlled prospective study was conducted on 60 patients with neck pain following rear-end collision between the ages of 20 to 50 years. Written informed consent was obtained and participants were randomly allocated to transcutaneous electrical nerve stimulation (TENS) and SCENAR therapy. The treatment regimen included 20-min treatment sessions for 4 weeks (3 times per week). Therapeutic effects were evaluated at each of the assessment points (0, 4, 8, 12 and 16 weeks) using a visual analogue scale (VAS) pain scores and neck disability index (NDI) scores.
Eligible participants (n=70) were recruited between March 2014 and July 2015. Final trial sample (n=60) compromised 32 within the SCENAR group and 28 TENS group. The SCENAR group showed superior pain reduction compared with TENS (SCENAR: initial mean VAS score; 6.3, final mean VAS score; 2.1, TENS: initial mean VAS score; 6.2, final mean VAS score; 3.7). Sixteen week NDI scores showed the disability level of the SCENAR group (9.5) was significantly lower than that of the TENS group (14.3).
SCENAR therapy provided a significant reduction in the intensity of neck pain (VAS) and disability (NDI) compared with TENS group. SCENAR therapy is superior to the TENS therapy in reducing and disability for whiplash injury.
RITMSCENAR was featured in the National Russian TV on 2nd of November 2016.
Prof. Dr. A. Tarakanov, Head of Emergency Department in the Rostov-on-Don Hospital, Russia talked about what is SCENAR, how does it work and why this technology is so successful in providing pain relief.